Refine by
Pharmaceutical Compounding Articles & Analysis
19 news found
Versatile compound shows promise in drug synthesis, metal chelation, antioxidant activity, and moreChangsha, China – May 22, 2025– Hunan Huateng Pharmaceutical Co., Ltd., a leading global supplier of PEG derivatives and pharmaceutical intermediates, is proud to offer high-purity N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7) to researchers ...
It helps assess the purity and authenticity of pharmaceutical compounds, ensuring compliance with regulatory standards. Another essential test is the melting point test, which determines the temperature at which a substance changes from a solid to a liquid state. ...
The conference, which is one of the largest gatherings of chemists and scientific researchers in the world, provided Alfa Chemistry with an opportunity to showcase its latest products and technologies, including its revolutionary isotope compounds, active pharmaceutical ingredients (APIs), extracted peptides, protection reagents, nanomaterials, precious metal ...
Application No. 17/546,880 filed on December 9, 2021 and titled Complexing Agent Salt Formulations of Pharmaceutical Compounds. Bexson’s formulation platform, branded as SeValent, is the basis for the Company’s lead ketamine therapy, BB106. ...
“This divestment is part of the ongoing transformation of our pharmaceuticals business, which focuses on key areas of healthcare innovation,” said Marianne De Backer, PhD, MBA, Member of the Executive Committee and EVP, Head Strategy and Business Development & Licensing and Open Innovation, Pharmaceuticals Division of Bayer AG. ...
ByBayer AG
Below is a detailed list of BOC Sciences highlights presented at the BIO conference this year: Fermentation for APIs & Bioactive Metabolites: Multiple strain development strategies including mutation, selection, cloning, and genetic recombination Extensive product portfolio of metabolites up to kilogram scales Successful delivery in 20+ high potent API projects Preclinical CRO Services: ...
Its comprehensive fermentation CDMO services and small microbial molecules have delivered tremendous value to the pharmaceutical industry. And the future looks even better. Pharmaceutical enterprises have been confronted with numerous challenges, such as rising cost pressures and uncertainty in the upstream supply of APIs, antibodies, enzymes, therapeutic ...
Many drug candidates unfortunately stopped their way ahead from the discovery pipeline just simply because they are poorly water-soluble, which further leads to poor bioavailability. Pharmaceutical excipients play magic roles to achieve better drug delivery and adoption. ...
GLK-301 is the first investigational drug candidate utilizing Glaukos’ iLution platform’s patented cream-based drug formulations that are applied to the outer surface of the eyelid for dropless transdermal delivery of pharmaceutically active compounds for the treatment of eye disorders. GLK-301’s active pharmaceutical ingredient ...
GLK-302 is the second investigational drug candidate utilizing Glaukos’ iLution platform’s patented cream-based drug formulations that are applied to the outer surface of the eyelid for dropless transdermal delivery of pharmaceutically active compounds for the treatment of eye disorders. GLK-302’s active pharmaceutical ...
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning Life Science/Pharmaceutical company developing formulations combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced the filing of its International Patent, trade named Mentanine, which has ...
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced that Rob Rinderman has joined CanaQuest as its new Director of ...
CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the “Company” or “CanaQuest“), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced it has been awarded the International CBD Life Science R & D Excellence Award ...
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced that Fundamental Research Corp (“FRC”), one of the world’s largest ...
Canaquest Medical Corp (OTC Markets: “CANQF”) (the “Company” or “CanaQuest”), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), is pleased to announce its new partnership with the Canadian Cannabis Dispute ...
Hanover, Germany, October 22, 2020 - Cardior Pharmaceuticals GmbH, a clinical-stage biotech company, focused on the development of noncoding RNA (ncRNA) therapeutics for patients with cardiovascular diseases, today announced a publication in the European Heart Journal (doi:10.1093/eurheartj/ehaa791) demonstrating that repeated treatment with its lead compound ...
Research results were published in the July/August 2014 issue: International Journal of Pharmaceutical Compounding. "The research shows that using a toothpaste delivery system to treat patients with seasonal allergies is very promising," said Rudner. ...
The research results were published in the July/August 2014 issue: International Journal of Pharmaceutical Compounding. "The research shows that using a toothpaste delivery system to treat patients with seasonal allergies is very promising," said Dr. ...
Beta Chem previously used the 2,000-square-foot facility, situated in the Noon Industrial Park, for the synthesis of radioactive carbon-14 into pharmaceutical compounds for medical research. Between 2006 and 2012, the Kansas Department of Health and Environment (KDHE) tried to compel the company to attain compliance with its Radioactive Materials License, but the ...